Pancreatic Cancer Research

ResearcherHunter Medical Research InstituteNo recent work listed

Hubert Hondermarck

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3807-2985; OpenAlex author ID A5048022663. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2020: 3 papers · 2021: 1 paper · 2022: 1 paper

Papers 5

  1. Proteome and secretome analysis of pancreatic cancer cells. Last author DOI 10.1002/pmic.202100320↗
  2. Tumor innervation and clinical outcome in pancreatic cancer. Last author DOI 10.1038/s41598-021-86831-w↗
  3. Cold Shock Domain Containing E1 (CSDE1) Protein is Overexpressed and Can be Targeted to Inhibit Invasiveness in Pancreatic Cancer Cells. Last author DOI 10.1002/pmic.201900331↗
  4. The Membrane Protein Sortilin Can Be Targeted to Inhibit Pancreatic Cancer Cell Invasion. Last author DOI 10.1016/j.ajpath.2020.05.018↗
  5. Schwann Cell Stimulation of Pancreatic Cancer Cells: A Proteomic Analysis. Last author DOI 10.3389/fonc.2020.01601↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiang Li · 4 shared papers, 2020–2022 · strength 0.53
  2. Fangfang Gao · 3 shared papers, 2020–2021 · strength 0.34
  3. Aysha Ferdoushi · 2 shared papers, 2020–2021 · strength 0.22
  4. Hui Liu · 1 shared paper, 2022 · strength 0.17
  5. Hui Liu · 1 shared paper, 2020 · strength 0.13
  6. Hui Liu · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.